Literature DB >> 23143126

Transcatheter aortic valve implantation: prevention and management of complications.

Stefan Stortecky1, Lutz Buellesfeld, Peter Wenaweser, Stephan Windecker.   

Abstract

Assessment of elderly patients with severe aortic stenosis and decisions in terms of management strategy (conservative with or without balloon aortic valvuloplasty, transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement) are complex and warrant a multidisciplinary approach involving collaboration between experienced cardiac surgeons, interventional cardiologists, cardiac imaging specialists, anaesthesiologists, geriatricians and a specialised nursing staff. Patient history, comorbid conditions, perioperative risk stratification as well as anatomical and procedural considerations require careful review on an individual, case-by-case basis and have a major impact on treatment allocation. The aims of this article are to provide insights into the fundamental role of appropriate patient screening and selection, and to review the nature, management and prevention of the most important procedural complications associated with the TAVI procedure.

Entities:  

Mesh:

Year:  2012        PMID: 23143126     DOI: 10.1136/heartjnl-2012-302403

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  3 in total

1.  Imaging for approach selection of TAVI: assessment of the aorto-iliac tract diameter by computed tomography-angiography versus projection angiography.

Authors:  E M A Wiegerinck; H A Marquering; N Y Oldenburger; M A Elattar; R N Planken; B A J M De Mol; J J Piek; J Baan
Journal:  Int J Cardiovasc Imaging       Date:  2013-12-11       Impact factor: 2.357

2.  Update of transcatheter valve treatment.

Authors:  Xian-bao Liu; Jian-an Wang
Journal:  J Zhejiang Univ Sci B       Date:  2013-08       Impact factor: 3.066

Review 3.  Transcatheter aortic valve insertion (TAVI): a review.

Authors:  B Clayton; G Morgan-Hughes; C Roobottom
Journal:  Br J Radiol       Date:  2013-11-20       Impact factor: 3.039

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.